For the off-season athlete there is no anabolic steroid more important or beneficial than testosterone. High levels of testosterone will promote significant increases in lean muscle mass and strength. This is assuming that the individual is consuming adequate calories. Compounds like Testosterone Propionate are not magical, you will still need to feed your body enough calories. During an off-season period of growth, this means total caloric intake will need to be slightly above maintenance. This will, unfortunately, promote body fat gain. However, the key to a successful off-season is gaining lean tissue while minimizing body fat gain to the fullest extent possible. By supplementing with Testosterone Propionate you will be able to achieve this more efficiently. High testosterone levels will promote a stronger metabolic rate. This is not a license to eat like there’s no end in sight, but you should be able to make better use of your calories.
Dosage and duration of therapy with Delatestryl depends on the age, sex, diagnosis, patient's response to treatment, and appearance of adverse effects. Delatestryl may interact with blood thinners, or corticosteroids. Tell your doctor all medications and supplements you use. Delatestryl must not be used during pregnancy. It may harm a fetus. It is recommended that women use 2 forms of birth control (., condoms and birth control pills) while using this medication; consult your doctor. It is unknown if this drug passes into breast milk. It may affect milk production and it may harm a nursing infant. Breastfeeding while using this drug is not recommended.
North America, powered by strong demand for advanced TRT products in the ., dominates the global testosterone replacement market by accounting for almost % share in it. In fact, the . occupied about % of the North America market in 2015. Europe follows North America vis-à-vis market share. Other important markets are Asia Pacific, the Middle East and Africa (MEA), and Latin America. Asia Pacific is expected to exhibit speedy growth because of significantly higher healthcare investments. China and India hold out a solid potential for the TRT market. South Korea and Japan too will impact sales positively due to a growing population of geriatrics. In Latin America, Brazil is the primary TRT market with maximum share.